PROSTINE VR 0.5 mg/ml, solution for injection ampoule
Active ingredients: ALPROSTADIL
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injectionampouleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PROSTINE VR 0,5 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 ampoule(s) en verre
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Apr 1987
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68103252CIP75541551CIP133400955415510Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALPROSTADILsolution | 0,5 mg · 1 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: ALPROSTADIL 0,5 mg/ml - PROSTINE VR 0,5 mg/ml, solution injectable.